Literature DB >> 1457196

Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals.

S Escaich1, J Ritter, P Rougier, D Lepot, J P Lamelin, M Sepetjan, C Trepo.   

Abstract

Changes in HIV replication during progression of HIV infection were assessed by estimation of the number of peripheral blood mononuclear cells (PBMC) harboring HIV proviral sequences. Samples from 23 patients at different stages of HIV infection were analyzed by quantitative polymerase chain reaction (PCR) using GAG primers. HIV titers in PBMC were also determined by serial dilutions of cells in coculture with phytohemagglutinin-activated normal PBMC. A positive correlation was observed between the number of HIV DNA copies and the HIV titer in PBMC. The PCR test was more sensitive than the coculture technique. The number of HIV copies detected by PCR ranged from 50 to 10,500 per 10(6) PBMC: assuming one copy per cell this implies a frequency of proviral HIV-containing cells of one per 100 to one per 20,000 mononuclear cells. The mean number of HIV DNA sequences in PBMC was significantly lower in asymptomatic patients than in AIDS patients and patients with AIDS-related complex (ARC). In patients who progressed from asymptomatic infection to AIDS, the number of HIV DNA copies in PBMC rose, indicating an increase of HIV replication. These results show that the number of infected PBMC increases during clinical progression. However, some asymptomatic patients had a higher number of HIV DNA copies in their PBMCs suggesting that increased HIV replication precedes the appearance of clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457196     DOI: 10.1089/aid.1992.8.1833

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Simple procedure for estimating the efficiency of PCR.

Authors:  A S Bourinbaiar; K Ajuang-Simbiri
Journal:  Mol Biotechnol       Date:  1996-08       Impact factor: 2.695

2.  Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.

Authors:  Amanda McNulty; Cheryl Jennings; Diane Bennett; Joseph Fitzgibbon; James W Bremer; Michael Ussery; Marcia L Kalish; Walid Heneine; J Gerardo García-Lerma
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

3.  Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.

Authors:  N Désiré; A Dehée; V Schneider; C Jacomet; C Goujon; P M Girard; W Rozenbaum; J C Nicolas
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.